Results 111 to 120 of about 72,644 (316)

Retrospective Study Evaluating Outcomes Following Palliative Radiotherapy With or Without Chemotherapy for Dogs With Presumed Cardiac Hemangiosarcoma

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Canine cardiac hemangiosarcoma (cHSA) represents a complex clinical challenge in that those afflicted have an acute risk of death due to cardiac tamponade and high morbidity and mortality given the frequency of metastasis. Previous studies show that radiation therapy (RT) can decrease the risk of tamponade; however, an optimal approach has yet
Cory N. Wakamatsu   +4 more
wiley   +1 more source

How Can We Stop Cancer? [PDF]

open access: yes, 2020
Cancer is a disease that humans have been struggling to combat for centuries. It originates from the accumulation of several mutations over the life of a cell that causes it to evade cell death and multiply rapidly.
Current, Joseph R
core   +1 more source

European guidelines for the management of malignant pleural mesothelioma [PDF]

open access: yes, 2011
Malignant Pleural Mesothelioma (MPM) is nearly invariably lethal tumor of the pleura. Significant therapeutic nihilism exists among health professionals. Recent progress has reshaped the clinical landscape in the treatment of MPM. Two European guidelines
van Thiel, Eric   +2 more
core   +2 more sources

Diagnostic performance of SHOX2 and RASSF1A gene methylation assays in malignant pleural effusion: A systematic review and meta‐analysis

open access: yesCancer Cytopathology, Volume 133, Issue 8, August 2025.
Abstract Background Malignant pleural effusion (MPE) is a common complication of advanced malignancies, requiring differentiation from benign pleural effusion for appropriate management. Cytology and biopsy have limitations, necessitating more sensitive, less invasive diagnostic techniques.
Mohamed Smail Aissani   +12 more
wiley   +1 more source

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

open access: yesThe Lancet, 2021
P. Baas   +20 more
semanticscholar   +1 more source

The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.

open access: yesJournal of Thoracic Disease, 2018
Malignant pleural mesothelioma (MPM), an asbestos-induced tumor, represents significant diagnostic challenges for pathologists. Its histological diagnosis is stepwise and should be based on morphological assessment, supported by clinical and radiological
G. Alí, R. Bruno, G. Fontanini
semanticscholar   +1 more source

Malignant pleural mesothelioma forming a huge mediastinal mass and causing atrial fibrillation

open access: yesIndian Journal of Pathology and Microbiology, 2012
A patient with malignant pleural mesothelioma was admitted with atrial fibrillation. Chest computed tomography showed a huge mediastinal tumor adjacent to the heart.
Hiroko Kuwabara   +3 more
doaj   +1 more source

A Rare Tumor in a Septuagenarian Female 16 Years After Radical Mastectomy for Breast Carcinoma

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Pleuropulmonary spindle cell carcinoma (SpCC) is a very rare tumor that belongs to a subgroup of sarcomatoid carcinomas of non‐small cell carcinomas of the lung. Breast carcinoma is one of the most common malignancies associated with metachronous second primary cancers.
Mohammadhossein Rahimirad   +4 more
wiley   +1 more source

Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma [PDF]

open access: yes, 2017
Introduction: Malignant mesothelioma is a rare and lethal malignancy primarily affecting the pleura and peritoneum. Mesothelioma incidence is expected to increase worldwide and current treatments remain ineffective, leading to poor prognosis. Within this
Bakker, Emyr   +5 more
core   +2 more sources

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment

open access: yesEuropean Medical Journal Oncology, 2017
Pleural malignancies constitute either primary pleural malignancies, such as malignant pleural mesothelioma (MPM), or secondary pleural tumours, either from pleural metastasis or direct extension of adjacent tumours.
Aline N. Zouk, Hitesh Batra
doaj  

Home - About - Disclaimer - Privacy